[go: up one dir, main page]

WO2009112763A3 - Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu - Google Patents

Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu Download PDF

Info

Publication number
WO2009112763A3
WO2009112763A3 PCT/FR2009/050303 FR2009050303W WO2009112763A3 WO 2009112763 A3 WO2009112763 A3 WO 2009112763A3 FR 2009050303 W FR2009050303 W FR 2009050303W WO 2009112763 A3 WO2009112763 A3 WO 2009112763A3
Authority
WO
WIPO (PCT)
Prior art keywords
lipase
compound
bioconvertible
light ray
activates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2009/050303
Other languages
English (en)
Other versions
WO2009112763A2 (fr
Inventor
Francine Baldo
Quang Lan Nguyen
Dang-Man Pham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to BRPI0905990-3A priority Critical patent/BRPI0905990A2/pt
Priority to EP09718596A priority patent/EP2257269A2/fr
Priority to US12/919,371 priority patent/US20110130704A1/en
Priority to JP2010547237A priority patent/JP5791903B2/ja
Publication of WO2009112763A2 publication Critical patent/WO2009112763A2/fr
Publication of WO2009112763A3 publication Critical patent/WO2009112763A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/81—Preparation or application process involves irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention se rapporte à un procédé cosmétique destiné notamment à améliorer l'apparence de la peau et/ou du cheveu comprenant l'administration simultanée et/ou séquentielle : a) d'au moins un composé bioconvertible par la lipase; et b) d'au moins un rayonnement lumineux présentant au moins une longueur d'onde prédominante activant la lipase. En particulier, ledit rayonnement lumineux selon l'invention présente (émet) au moins une longueur d'onde prédominante activant la lipase allant de 400 à 510nm, de préférence de 430 à 500nm, et est utilisé de préférence à une dose allant de 0,01 à 200J/cm2, de préférence de 0,1 à 30J/cm2, plus préférentiellement de 1 à 30J/cm2, voire de 5 à 30J/cm2. L'invention se rapporte également à une composition comprenant au moins un composé bioconvertible par la lipase et au moins un composé émettant et/ou filtrant, notamment sous exposition lumineuse, un rayonnement lumineux présentant au moins une longueur d'onde prédominante activant la lipase, ainsi qu'à un kit comprenant au moins une composition comprenant au moins un composé bioconvertible par la lipase et un dispositif et/ou un composé émettant/filtrant un rayonnement lumineux présentant au moins une longueur d'onde prédominante activant la lipase.
PCT/FR2009/050303 2008-02-25 2009-02-25 Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu Ceased WO2009112763A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
BRPI0905990-3A BRPI0905990A2 (pt) 2008-02-25 2009-02-25 "método cosmético, combinação, composição e kits"
EP09718596A EP2257269A2 (fr) 2008-02-25 2009-02-25 Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu
US12/919,371 US20110130704A1 (en) 2008-02-25 2009-02-25 Combination of a light ray and a lipase-bioconvertible compound for improving skin and/or hair appearance
JP2010547237A JP5791903B2 (ja) 2008-02-25 2009-02-25 皮膚および／または髪の外観を改善するための、光線とリパーゼにより生物学的に変換可能な化合物との組合せ

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0851178 2008-02-25
FR0851178A FR2927800A1 (fr) 2008-02-25 2008-02-25 Association d'un rayonnement lumineux et d'un compose bioconvertible par la lipase pour ameliorer l'apparence de la peau et/ou du cheveu.
US3297608P 2008-03-02 2008-03-02
US61/032,976 2008-03-02

Publications (2)

Publication Number Publication Date
WO2009112763A2 WO2009112763A2 (fr) 2009-09-17
WO2009112763A3 true WO2009112763A3 (fr) 2010-06-24

Family

ID=40001485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/050303 Ceased WO2009112763A2 (fr) 2008-02-25 2009-02-25 Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu

Country Status (6)

Country Link
US (1) US20110130704A1 (fr)
EP (1) EP2257269A2 (fr)
JP (1) JP5791903B2 (fr)
BR (1) BRPI0905990A2 (fr)
FR (1) FR2927800A1 (fr)
WO (1) WO2009112763A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5797432B2 (ja) * 2011-03-24 2015-10-21 エスエス製薬株式会社 白髪防止剤
US9624425B2 (en) 2012-09-01 2017-04-18 Prolume, Ltd. Substituted benzo[f]imidazo[1,2-a]quinoxalines and imidazo[1,2-a]pyrazines
US10180248B2 (en) 2015-09-02 2019-01-15 ProPhotonix Limited LED lamp with sensing capabilities
US20180280286A1 (en) * 2017-03-31 2018-10-04 L'oreal Compositions and treatments for keratinous materials providing damage protection and sensorial benefits
CN109575633B (zh) * 2018-12-28 2020-01-14 中国科学院西北高原生物研究所湖州高原生物资源产业化创新中心 一种黑果枸杞蓝色提取物及其制备方法
US12064504B2 (en) 2021-10-31 2024-08-20 L'oreal Cosmetic compositions comprising high amounts of trifluoromethylhenyl valylglycine
KR20240099370A (ko) 2021-10-31 2024-06-28 로레알 고용량의 세라마이드-np를 포함하는 화장료 조성물
KR102416730B1 (ko) * 2021-11-09 2022-07-05 주식회사 유나이티드엑티브 피부상재균을 이용한 식물성 발효 오일의 제조방법 및 이를 포함하는 화장료 조성물
WO2025115170A1 (fr) * 2023-11-30 2025-06-05 Smc株式会社 Solution de test de fluorescence
WO2025115169A1 (fr) * 2023-11-30 2025-06-05 Smc株式会社 Liquide d'inspection fluorescent

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380335A2 (fr) * 1989-01-27 1990-08-01 Lancaster Societe Anonyme Monegasque Compositions accélérant le bronzage
US5658580A (en) * 1993-09-09 1997-08-19 Chanel, Inc. Skin cream composition
FR2759902A1 (fr) * 1997-02-24 1998-08-28 Clarins Baton de rouge a levres comprenant un coeur et une ecorce
US6346255B1 (en) * 1998-01-15 2002-02-12 Lavipharm Laboratories Inc. Plant polar lipid permeation enhancer in a cosmetic pad for improving skin appearance
WO2002028361A2 (fr) * 2000-09-29 2002-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions de nettoyage de peau et de traitement d'acne
WO2003017824A2 (fr) * 1998-11-30 2003-03-06 Light Bioscience, Inc. Methode et appareil pour le traitement de l'acne
WO2003028740A1 (fr) * 2001-10-04 2003-04-10 R & Derm Ltd. Compositions servant au traitement d'inflammations de la glande pilosebacee et renfermant du fluorure d'aluminium
DE102004002602A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
WO2005094764A1 (fr) * 2004-03-12 2005-10-13 The Gillette Company Produits de gel de rasage
US20050271692A1 (en) * 2002-06-25 2005-12-08 Cosmeceutic Solutions Pty. Ltd. Topical cosmetic compositions
US20050276761A1 (en) * 2004-06-11 2005-12-15 Gupta Shyam K Zeolite based UV Absorbing and Sunscreen Compositions
WO2005120572A1 (fr) * 2004-06-09 2005-12-22 Qlt Inc. Thérapie photodynamique pour le traitement d'affections des glandes sébacées hyperactives en utilisant des porphyrines vertes hydrophobes appliquées localement
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
US20070141012A1 (en) * 2002-07-31 2007-06-21 Melaleuca, Inc. Skin Care Compositions
US20070166255A1 (en) * 2004-11-22 2007-07-19 Gupta Shyam K Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985929A (en) * 1998-11-05 1999-11-16 Kern; Jerome Cold chemical sterilant
US20070010580A1 (en) * 2003-05-30 2007-01-11 Gianfranco De Paoli Ambrosi Formulation for chemical peeling
CA2457214A1 (fr) * 2004-02-06 2005-08-06 Qlt Inc. Therapie photodynamique pour le traitement de l'acne
GB0403115D0 (en) * 2004-02-12 2004-03-17 Givauden Sa Organic compounds
CN1984695A (zh) * 2004-07-16 2007-06-20 强生消费者公司 用光和有益试剂治疗皮肤以缓解痤疮
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20070098670A1 (en) * 2005-11-01 2007-05-03 Melissa Jochim Compositions and methods for using juice organic, juice based skin care products

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380335A2 (fr) * 1989-01-27 1990-08-01 Lancaster Societe Anonyme Monegasque Compositions accélérant le bronzage
US5658580A (en) * 1993-09-09 1997-08-19 Chanel, Inc. Skin cream composition
FR2759902A1 (fr) * 1997-02-24 1998-08-28 Clarins Baton de rouge a levres comprenant un coeur et une ecorce
US6346255B1 (en) * 1998-01-15 2002-02-12 Lavipharm Laboratories Inc. Plant polar lipid permeation enhancer in a cosmetic pad for improving skin appearance
WO2003017824A2 (fr) * 1998-11-30 2003-03-06 Light Bioscience, Inc. Methode et appareil pour le traitement de l'acne
WO2002028361A2 (fr) * 2000-09-29 2002-04-11 Johnson & Johnson Consumer Companies, Inc. Compositions de nettoyage de peau et de traitement d'acne
WO2003028740A1 (fr) * 2001-10-04 2003-04-10 R & Derm Ltd. Compositions servant au traitement d'inflammations de la glande pilosebacee et renfermant du fluorure d'aluminium
US20050271692A1 (en) * 2002-06-25 2005-12-08 Cosmeceutic Solutions Pty. Ltd. Topical cosmetic compositions
US20070141012A1 (en) * 2002-07-31 2007-06-21 Melaleuca, Inc. Skin Care Compositions
DE102004002602A1 (de) * 2004-01-15 2005-08-04 Beiersdorf Ag Visualisierung von Sonnenschutzmitteln auf der Haut
WO2005094764A1 (fr) * 2004-03-12 2005-10-13 The Gillette Company Produits de gel de rasage
WO2005120572A1 (fr) * 2004-06-09 2005-12-22 Qlt Inc. Thérapie photodynamique pour le traitement d'affections des glandes sébacées hyperactives en utilisant des porphyrines vertes hydrophobes appliquées localement
US20050276761A1 (en) * 2004-06-11 2005-12-15 Gupta Shyam K Zeolite based UV Absorbing and Sunscreen Compositions
US20070166255A1 (en) * 2004-11-22 2007-07-19 Gupta Shyam K Treatment of Topical Discomforts Including Acne, Sunburn, Diaper Rash, Wound, Wrinkles and Dandruff/Hair Loss by Natural Lignans via Fatty Acid Desaturase Inhibition
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne

Also Published As

Publication number Publication date
EP2257269A2 (fr) 2010-12-08
US20110130704A1 (en) 2011-06-02
BRPI0905990A2 (pt) 2015-06-30
FR2927800A1 (fr) 2009-08-28
JP5791903B2 (ja) 2015-10-07
WO2009112763A2 (fr) 2009-09-17
JP2011513213A (ja) 2011-04-28

Similar Documents

Publication Publication Date Title
WO2009112763A3 (fr) Association d'un rayonnement lumineux et d'un composé bioconvertible par la lipase pour améliorer l'apparence de la peau et/ou du cheveu
WO2005105113A3 (fr) Composition therapeutique contenant au moins un derive de la pyrrolobenzodiazepine et la fludarabine
NO20071428L (no) Kombinasjon inneholdende ZD6474 og Imatinib
EP2100614B8 (fr) Anticorps contre PDGFR-alpha pour l'utilisation dans le traitement de tumeurs
TW200714283A (en) Method and composition for treating peripheral vascular diseases
IL202106A0 (en) Gaboxadol for treating depression and other affective disorders
WO2005120461A3 (fr) Formulations liposomales renfermant de la dihydrosphingomyeline, et procedes d'utilisation correspondants
SG140589A1 (en) Therapy device and related accessories, compositions, and treatment methods
GB0420888D0 (en) Compounds and uses
WO2007011962A3 (fr) Traitement du cancer
WO2007058942A3 (fr) Imidazopyrazines inhibant la proteine kinase
WO2010078985A3 (fr) Procédé cosmétique pour réguler le brunissement de la peau induit par un rayonnement uv et compositions
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2009118662A3 (fr) Compositions et méthodes de traitement de la perte osseuse
PL379983A1 (pl) Sposoby leczenia bólu polegające na podaniu antagonisty czynnika wzrostu nerwów i niesteroidowego leku przeciwzapalnego oraz zawierające je kompozycje
WO2006020722A3 (fr) Compositions pharmaceutiques de beta-lapachone et d'analogues de beta-lapachone possedant un potentiel de ciblage de tumeur ameliore
WO2005084295A3 (fr) Composes heterocycliques fusionnes utilises comme inhibiteurs de la 17b-hydroxysteroide dehydrogenase 3
MX2010007471A (es) Composiciones de nanoparticulas que proporcionan color mejorado para formulaciones cosmeticas.
SI1774972T1 (sl) Uporaba selenovega kvasa za zdravljenje Alzheimerjeve bolezni
WO2008132021A3 (fr) Mélanges fongicides
WO2005011590A3 (fr) Compositions et procedes pour le retablissement de la sensibilite au traitement par antagonistes vis-a-vis de her2
WO2006055352A3 (fr) Methodes de traitement du cancer avec des formulations de composes de platine a base lipipique administrees par voie intraperitoneale
TW200509863A (en) Irradiation device for medical use
WO2007067519A3 (fr) Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09718596

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010547237

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009718596

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12919371

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0905990

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100825